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This investigation was undertaken to determine whether a 
relation could be identified between left ventricular wall 
thickness and age in a large population of symptomatic 
patients with hypertrophic cardiomyopathy. Extent of left 
ventricular hypertrophy was assessed with two-dimensional 
echocardiography in 173 patients with hypertrophic car- 
diomyopathy who ranged in age from 21 to 74 years (mean 
45) and had mild to severe cardiac symptoms. 
The overall study group was classified into five age 
subgroups (each corresponding to a decade); maximal left 
ventricular wall thickness and wall thickness index (a 
quantitative expression of the overall extent of hypertro- 
phy) were assessed in each group. These two indexes were 
significantly higher in patients 21 to 30 years of age than in 
patients in each of the other four older age groups. The two 
Hypertrophic cardiomyopathy is characterized by a marked 
increase in left ventricular wall thickness (1,2). However, 
recent echocardiographic studies (3-5) have shown that the 
extent and distribution of left ventricular hypertrophy in 
hypertrophic cardiomyopathy may undergo substantial 
changes, including progression of hypertrophy in children (3) 
and thinning of the left ventricular wall in some symptomatic 
adults (4,5). In addition, the most extreme degrees of left 
ventricular hypertrophy have been reported in young pa- 
tients with hypertrophic cardiomyopathy but appear to be 
largely uncommon in older patients (6). These observations 
suggest the possibility that, in adult patients with this dis- 
ease, the magnitude of left ventricular hypertrophy and age 
could be inversely related. To test this hypothesis, we 
investigated the relation between hypertrophy and age in a 
large group of patients with hypertrophic cardiomyopathy. 
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indexes of left ventricular hypertrophy were also signifi- 
cantly higher in patients 31 to 40 years of age than in 
patients who were 61 to 74 years old. Multivariate regres- 
sion analysis showed that the relation between wall thick- 
ness and age was not influenced by other clinical variables 
such as severity of symptoms, presence of subaortic ob- 
struction, left ventricular cavity dimension and gender. 
In conclusion, the findings indicate that, in a population 
of symptomatic adult patients with hypertrophic cardiomy- 
opathy, left ventricular hypertrophy is considerably more 
severe in younger than in older patients and that there is an 
inverse relation between left ventricular wall thickness and 
age. 
(J Am Co11 Cardiol1989;13:820-3) 
Methods 
Selection and characterization of patients. The present 
investigation comprises 173 patients with hypertrophic car- 
diomyopathy who were studied at the National Heart, Lung, 
and Blood Institute between February 1981 and November 
1985 and who met the following selection criteria: 1) they 
had a technically satisfactory two-dimensional echocardio- 
gram, with clear recognition of the endocardial and epicar- 
dial borders of the left ventricular wall, such as to permit a 
reliable assessment of the distribution and extent of left 
ventricular hypertrophy (3-8); 2) they were symptomatic at 
the time of their clinical and echocardiographic evaluation 
(New York Heart Association functional classes II to IV); 
and 3) they were >20 years of age. Patients who were 
asymptomatic were excluded because of the uncertainty of 
whether they would develop clinically overt manifestations 
of hypertrophic cardiomyopathy during their lifetime (9). 
Patients who were ~21 years old were also excluded from 
the present study because substantial increases in left ven- 
tricular wall thickness may occur in patients with hypertro- 
phic cardiomyopathy during childhood (3). 
The 173 study patients ranged in age from 21 to 74 years 
(mean 45); 103 (58%) were male. Eighty-three patients had 
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mild functional limitation (functional class II) and 90 had 
moderate to severe functional limitation (classes III and IV). 
At some time during their clinical course, all study patients 
fulfilled our diagnostic criterion for hypertrophic cardiomy- 
opathy: M-mode and two-dimensional echocardiographic 
demonstration of a hypertrophied, nondilated left ventricle 
in the absence of another cardiac or systemic disease that 
could produce left ventricular hypertrophy (IO). 
Presence of left ventricular oatflow tract obstruction 
under basal conditions was assessed at cardiac catheteriza- 
tion in 11 I patients: in the other 62 patients, it was estimated 
from the M-mode echocardiogram, based on the magnitude 
and duration of systolic anterior motion of the mitral valve 
(1 I ,12). Left ventricular outflow tract obstruction under 
basal conditions (gradient ~30 mm Hg) was present in 51 
patients and was absent in the other 122. 
Echocardiography. An Advanced Technology Labora- 
tory (ATL) Mark 500 mechanical sector scanner (84”) with a 
3 MHz transducer or a Varian V-3400 real-time, phased 
array, ultrasonic sector scanner (800) with a 2.25 MHz 
transducer was used to perform the two-dimensional echo- 
cardiographic studies. Images were recorded on 1 in. (2.54 
cm) reel to reel videotape. Two-dimensional echocardio- 
graphic studies were obtained in the parasternal long-axis 
and short-axis views and apical two and four chamber views 
with use of standard transducer positions (13). 
Assessment of the magnitude and extent of left ventricu- 
lar hypertrophy was obtained primarily from the parasternal 
short-axis planes; however. the parasternal long-axis and the 
apical views were also used to integrate the observations 
made from the short-axis views. In the parasternal short-axis 
plane, the left ventricle was divided into four regions that 
identified the anterior and posterior ventricular septum and 
the lateral and posterior left ventricular free walls (4,5,7,8). 
Wall thickness was assessed directly from the television 
monitor with the aid of calipers and a calibration scale 
produced by the instrument (3-8). Location of endocardial 
and epicardial borders was identified by viewing the perti- 
nent portions of videotape in slow motion and real-time 
modes (3-8). 
Maximuf wall thickness was defined in each patient as the 
greatest thickness identified in any of the four segments into 
which the left ventricle had been divided (3-5). A ,&l 
thickness index was also calculated by adding the measure- 
ments of maximal wall thickness obtained in each of the four 
left ventricular segments (4). The calculated score was 
considered a quantitative expression of the overall magni- 
tude of left ventricular hypertrophy. Measurements of max- 
imal left ventricular wall thickness and wall thickness index 
have previously been shown to have satisfactory reproduc- 
ibility (3,4). None of the study patients had hypertrophy 
confined to the most distal portion of the left ventricle (below 
the papillary muscle level), i.e., “apical hypertrophic car- 
diomyopathy” (14.15). 
In addition, M-mode echocardiograms were utilized to 
assess left \,entricular end-diastolic cavity dimension. Mea- 
surements were obtained either at the mitral valve level or 
just distal to the mitral valve leaflets, wherever end-diastolic 
dimension was maximal (3-8). 
To ensure that the assessment of magnitude and extent of 
left ventricular hypertrophy and the measurement of left 
ventricular end-diastolic cavity dimension were unbiased, 
echocardiograms were coded and all measurements were 
obtained without knowledge of patient age and identity. 
Analysis of data. In the overall study group the relation 
between left ventricular wall thickness and age was assessed 
by linear regression analysis; this relation was also tested 
after adjusting for gender, magnitude of symptoms (func- 
tional class). left ventricular end-diastolic cavity dimension 
and presence or absence of subaortic obstruction, with use 
of multiple regression analysis. In addition, the study group 
was analyzed after classifying the patients by age into five 
groups of similar size, each corresponding to a decade. The 
five age groups were: 21 to 30 years (30 patients), 31 to 40 
years (42 patients), 41 to 50 years (36 patients), 51 to 60 years 
(32 patients) and 61 to 74 years (33 patients). Differences in 
continuous variables among the five groups were assessed 
by analysis of variance: differences between proportions 
were assessed with the chi-square test. Data were expressed 
as mean values ? SD. 
Results 
Assessment of extent of hypertrophy. In the overall study 
group of 173 patients, an inverse relation was identified 
between age and maximal left ventricular wall thickness (r = 
-0.34, p < 0.001) and between age and the calculated index 
of left ventricular wall thickness (r = -0.33, p < 0.001). In 
addition, maximal left ventricular wall thickness and wall 
thickness index were significantly higher in the youngest age 
group (21 to 30 years) compared with each of the four older 
groups: these indexes were also significantly higher in pa- 
tients 3 1 to 40 years old compared with those 60 to 74 years 
of age (Table 1. Fig. 1 and 2). Maximal left ventricular wall 
thickness and wall thickness index did not differ significantly 
among the three older age groups. 
Multivariate analysis. To test whether gender, symptom- 
atic state, left ventricular end-diastolic cavity dimension and 
presence or absence of subaortic obstruction could have 
influenced the relation between age and left ventricular wall 
thickness, each of these variables was entered into a multi- 
variate analysis. After adjustment for these variables, the 
multivariate correlation coefficients between age and both 
maximal left ventricular wall thickness and wall thickness 
index remained similar to those achieved in the univariate 
analysis (r = -0.33, p < 0.001 for maximal wall thickness 
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Table 1. Echocardiographic and Clinical Variables in Five Age Groups of 173 Patients With Hypertrophic Cardiomyopathy 
Patient 
Group 
Maximal LV 
Wall Thickness 
(mm) 
LV Wall 
Thickness Index 
(mm) 
LVID, 
(mm) 
Gender 
(% male) 
Functional Class 
[no. (%)I 
II III-IV 
Basal LVOT 
Obstruction 
[no. (%)I 
21 to 30 years 24 + 6* 73 + 20* 43 * 6 57 14 (47) 16 (53) 9 (30) 
(30 patients) 
31 to 40 years 21 ? 5t 64 + l3t 45 2 6 61 22 (54) I9 (46) 8 (20) 
(42 patients) 
41 to 50 years I9 r 3 59? 11 43 + 6 67 22 (61) 14 (39) IO (28) 
(36 patients) 
51 to 60 years 20 t 4 59 * 10 45 ? 7 56 II (34) 21 (66) I3 (41) 
(32 patients) 
61 to 74 years I8 2 3 58 + 8 43 + 7 48 13 (39) 20 (61) 11 (33) 
(33 patients) 
*p < 0.02 when compared with values in patients 31 to 40 years old and p < 0.001 when compared with values in each of the other three age groups; 
.tp < 0.01 when compared with values in patients 61 to 74 years old. LV = left ventricular; LVID, = left ventricular end-diastolic diameter; LVOT = left 
ventricular outflow tract. 
and r = -0.32, p < 0.001 for wall thickness index). Further- 
more, gender, severity of cardiac symptoms, left ventricular 
end-diastolic cavity dimension and prevalence of subaortic 
obstruction were similar and not significantly different 
among the five age groups (Table 1). 
Discussion 
The results of the present investigation show that there is 
a relation between left ventricular wall thickness and age in 
symptomatic adult patients with hypertrophic cardiomyopa- 
thy. Younger patients showed substantially more severe and 
diffuse left ventricular hypertrophy than the older patients. 
Both maximal left ventricular wall thickness and wall thick- 
Figure 1. Comparison of maximal left ventricular (LV) wall thick- 
ness in five age groups of 173 patients with hypertrophic 
cardiomyopathy. 
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ness index were significantly greater in the younger patients 
(21 to 30 years) compared with each of the four older age 
groups. Both indexes were also substantially higher in the 
patients 31 to 40 years of age compared with the oldest age 
group (60 to 74 years). On the other hand, maximal wall 
thickness and wall thickness index did not show significant 
ditferences among the three older groups (41 to 50, 51 to 60 
and 61 to 74 years). Thus, the relation between wall thick- 
hess and age identified in our study is largely due to 
differences in wall thickness within the two youngest patient 
groups (~40 years of age) and between these two groups and 
the older patients (>40 years of age). These findings support 
previous observations (6), obtained in a selected group of 
patients with hypertrophic cardiomyopathy and massive left 
ventricular hypertrophy. Those observations suggested that 
the most extreme degrees of left ventricular hypertrophy are 
confined to youthful patients; of 34 patients with left ven- 
Figure 2. Comparison of left ventricular (LV) wall thickness index 
in, five age groups of 173 patients with hypertrophic cardiomy- 
opathy. 
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tricular wall thickness 235 mm (selected from a population 
of >700 patients with hypertrophic cardiomyopathy) none 
were >50 years and about 95% were ~40 years of age. 
The relation between wall thickness and age identified in 
our study does not appear to be influenced by other clinical 
variables such as severity of symptoms, presence of subaor- 
tic obstruction, left ventricular cavity dimension and gender. 
Multivariate regression analysis showed that magnitude of 
hypertrophy continued to correlate with age after adjustment 
for these variables. In addition, none of these variables were 
significantly different in the five age groups. 
Mechanisms and causative factors. The present study 
does not provide a definitive explanation for our finding that 
hypertrophy was substantially more severe in the younger 
than in the older patients. Because our investigation was not 
based on serial echocardiographic measurements, we cannot 
exclude the possibility that our findings were in part due to a 
higher rate of premature death in younger patients with 
severe left ventricular hypertrophy (16,17). However, we do 
not believe that this can be the only explanation for our 
findings because premature sudden death appears to be 
relatively uncommon in the overall population of patients 
with hypertrophic cardiomyopathy (18-21) and is not con- 
fined to young patients with severe hypertrophy (17). 
A second hypothesis to explain our results can be formu- 
lated on the basis of previous serial echocardiographic 
observations in patients with hypertrophic cardiomyopathy. 
Two recent studies (4.5), performed over a relatively brief 
period of follow-up (about 4 years) on a total of >I00 
patients with this disease, identified substantial decreases in 
left ventricular wall thickness in about 10% of the patients 
with severe symptoms. On the basis of these observations it 
is possible to speculate that a process of gradual and 
progressive wall thinning occurring over a long period of 
time in a large number of patients with hypertrophic cardio- 
myopathy could contribute to the inverse relation between 
wall thickness and age we identified in the present study. 
However. such a hypothesis could be proved only by 
performing serial echocardiograms over a long period of time 
in a large population of patients with this disease. These two 
possible explanations for our findings are not mutually 
exclusive. and it seems likely to us that both mechanisms 
may play a role in determining the morphologic differences 
that we have identified between younger and older patients 
with hypertrophic cardiomyopathy. 
We acknowledge the helpful statistical assistance of August0 Gamba, PhD. 
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